2005
DOI: 10.1152/ajpgi.00130.2005
|View full text |Cite
|
Sign up to set email alerts
|

A novel small molecule CFTR inhibitor attenuates HCO3 secretion and duodenal ulcer formation in rats

Abstract: Ϫ ) secretion (DBS). Although impaired DBS is observed in CF mutant mice and in CF patients, which would predict increased ulcer susceptibility, duodenal injury is rarely observed in CF patients and is reduced in CF mutant mice. To explain this apparent paradox, we hypothesized that CFTR dysfunction increases cellular [HCO 3 Ϫ ] and buffering power. To further test this hypothesis, we examined the effect of a novel, potent, and highly selective CFTR inhibitor, CFTR inh-172, on DBS and duodenal ulceration in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
34
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 31 publications
(39 citation statements)
references
References 51 publications
4
34
1
Order By: Relevance
“…‫,ءءء‬ P Ͻ 0.001. jpet.aspetjournals.org teamine treatment, i.p. injection of CFTR inh -172 (at 1 mg/ kg) 1 h before cysteamine treatment reduced duodenal ulceration (Akiba et al, 2005). Finally, CFTR inhibitors, such as CFTR inh -172, glibenclamide, and 5-nitro-2-(3-phenylpropylamino)-benzoic acid, by inhibiting transepithelial ion transport, retard renal cyst growth using MDCK cells as a model , suggesting that such molecules could contribute to the pharmacological treatment of autosomal-dominant polycystic kidney disease.…”
Section: Discussionmentioning
confidence: 99%
“…‫,ءءء‬ P Ͻ 0.001. jpet.aspetjournals.org teamine treatment, i.p. injection of CFTR inh -172 (at 1 mg/ kg) 1 h before cysteamine treatment reduced duodenal ulceration (Akiba et al, 2005). Finally, CFTR inhibitors, such as CFTR inh -172, glibenclamide, and 5-nitro-2-(3-phenylpropylamino)-benzoic acid, by inhibiting transepithelial ion transport, retard renal cyst growth using MDCK cells as a model , suggesting that such molecules could contribute to the pharmacological treatment of autosomal-dominant polycystic kidney disease.…”
Section: Discussionmentioning
confidence: 99%
“…Bafilomycin (Enzo Life Sciences) was used to inhibit the apical VHA and prepared in DMSO at 1.0 mmol/l for application in a final concentration of 2 mol/l and 0.1% DMSO, which has been previously used in the Gulf toadfish (27,31). CFTRinh-172 (Sigma) was used to inhibit a putative apical CFTR channel (1,6,7,48) and prepared in DMSO at 1.0 mmol/l for application in a final concentration of 10 mol/l and 0.1% DMSO, which is in the mid-range solubility limit for this blocker (1).…”
Section: Methodsmentioning
confidence: 99%
“…Unlike ATP, which activates P2Y G q/11 receptors followed by the increase of cellular Ca 2ϩ , ADO activates P1 G i receptors (A 1 and A 3 ) or G s receptors (A 2A and A 2B ). The latter receptors increase adenylate cyclase activity, which elevates cellular cAMP, directly activating the cystic fibrosis transmembrane regulator (CFTR), an important component of active DBS (Hogan et al, 1997;Seidler et al, 1997;Hirokawa et al, 2004;Akiba et al, 2005). There is, however, no published study addressing the effect of luminal ADO on bicarbonate secretion.…”
Section: Introductionmentioning
confidence: 99%